Trial intelligence / Profile preview

VEAPS: Vitamin E Atherosclerosis Prevention Study

NCT00114387Phase 3Completed

Sponsor
National Institute on Aging
Start
Jul 1996
Primary completion
Sep 2000
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of all-rac-α-tocopherol in atherosclerosis (2 arms), sponsored by National Institute on Aging. Primary endpoint: Rate of change of the distal common carotid artery far wall intima-media thickness at 24 months. Started Jul 1996; status: completed.

02

Drugs

all-rac-α-tocopherol
03

Conditions

atherosclerosis

Beyond the preview

Go deeper on NCT00114387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00114387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call